Last €14.20 EUR
Change Today +0.28 / 2.01%
Volume 66.8K
ROVI On Other Exchanges
Symbol
Exchange
Berlin
Continuous
As of 11:38 AM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

laboratorios farmaceuticos r (ROVI) Snapshot

Open
€13.94
Previous Close
€13.92
Day High
€15.00
Day Low
€13.55
52 Week High
02/27/15 - €15.00
52 Week Low
10/17/14 - €7.90
Market Cap
710.0M
Average Volume 10 Days
48.7K
EPS TTM
€0.48
Shares Outstanding
50.0M
EX-Date
--
P/E TM
29.5x
Dividend
€0.17
Dividend Yield
1.14%
Current Stock Chart for LABORATORIOS FARMACEUTICOS R (ROVI)

Related News

No related news articles were found.

laboratorios farmaceuticos r (ROVI) Related Businessweek News

No Related Businessweek News Found

laboratorios farmaceuticos r (ROVI) Details

Laboratorios Farmacéuticos ROVI, S.A. engages in the research, development, licensing, manufacture, and marketing of small molecule and biological medical specialties in Spain and internationally. Its flagship product is Bemiparin, a low molecular weight heparin. The company’s prescription products comprise Hibor to prevent thromboembolic disease; Osseor to treat osteoporosis; Hepadren for the prevention of clotting in the extracorporeal circuit; Hirobriz and Ulunar Breezhaler for the treatment of treatment of chronic obstructive pulmonary disease; Glufan for relieving symptoms of degenerative osteoarthritis(OA); and Corlentor for treating coronary artery disease and chronic heart failure. Its prescription products also include Exxiv for relieving the symptoms of OA, rheumatoid arthritis, ankylosing spondylitis,, and acute gouty arthritis; Calcio y Vitamina D3 ROVI to treat osteoporosis; Bertanel to treat adults active rheumatoid, juvenile idiopatic, and psoriatic arthritis; Vytorin for patients with primary hypercholesterolaemia or mixed hyperlipidaemia; Absorcol for patients with hypercholesterolaemia and phytosterolaemia; and Thymanax for treating depressive episodes in adults. In addition, the company offers diagnostic products, such as SonoVue for use in ultrasound imaging of echogenicity of the blood; and Iopamiro and Iomeron contrast, radiographic media for diagnosis by computed tomography and X-ray diagnostic techniques; and Multihance and Prohance for use in diagnostic magnetic resonance imaging. Further, it provides OTC products comprising Perspirex to control sweating from the armpits; Enerzone, a protein product; Dentimelo to repair oral mucosal lesions and gums; ColdPack cold and hot bag for reliving pain; and Nitview Ledcomb that optimizes the extraction of lice and nits. Additionally, the company distributes products licensed from other laboratories. Laboratorios Farmacéuticos ROVI, S.A. was founded in 1946 and is based in Madrid, Spain.

Founded in 1946

laboratorios farmaceuticos r (ROVI) Top Compensated Officers

Chief Executive Officer, Director and Member ...
Total Annual Compensation: €410.0K
Chairman of The Board, Chief Executive Office...
Total Annual Compensation: €244.0K
Chief Financial Officer, Director and Member ...
Total Annual Compensation: €305.0K
Director of Corporate Development and Directo...
Total Annual Compensation: €303.0K
Compensation as of Fiscal Year 2013.

laboratorios farmaceuticos r (ROVI) Key Developments

Laboratorios Farmaceuticos ROVI, S.A. to Report Fiscal Year 2014 Results on Feb 26, 2015

Laboratorios Farmaceuticos ROVI, S.A. announced that they will report fiscal year 2014 results Pre-Market on Feb 26, 2015

Laboratorios Farmaceuticos ROVI, S.A., 2014 Earnings Call, Feb 26, 2015

Laboratorios Farmaceuticos ROVI, S.A., 2014 Earnings Call, Feb 26, 2015

Laboratorios Farmaceuticos ROVI, S.A. Presents at Jefferies 2014 Global Healthcare Conference: London, Nov-19-2014 12:20 PM

Laboratorios Farmaceuticos ROVI, S.A. Presents at Jefferies 2014 Global Healthcare Conference: London, Nov-19-2014 12:20 PM. Venue: The Waldorf Hilton, Aldwych, London, United Kingdom.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ROVI:SM €14.20 EUR +0.28

ROVI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ROVI.
View Industry Companies
 

Industry Analysis

ROVI

Industry Average

Valuation ROVI Industry Range
Price/Earnings 25.9x
Price/Sales 2.7x
Price/Book 4.1x
Price/Cash Flow 19.2x
TEV/Sales 2.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LABORATORIOS FARMACEUTICOS R, please visit www.rovi.es. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.